GlassScriptDysis V3 Digital Coploscope
Payments companies reported to CMS as associated with Dysis V3 Digital Coploscope. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Dysis V3 Digital Coploscope, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Dysis V3 Digital Coploscope
These are the largest totals companies reported as associated with Dysis V3 Digital Coploscope. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Diana Herrera | Houston, TX | Obstetrics & Gynecology | $132.93 |
| Sanaz Amini | Loma Linda, CA | Obstetrics & Gynecology | $124.28 |
| Alireza Abidi | Sacramento, CA | Gynecologic Oncology | $124.28 |
| Deborah Arden | Boston, MA | $124.28 | |
| Alia Shbeeb | Riverside, CA | Obstetrics & Gynecology | $124.28 |
| Mazdak Momeni | Loma Linda, CA | Gynecologic Oncology | $124.27 |
| Scott Lentz | Los Angeles, CA | Gynecologic Oncology | $124.27 |
| Elena Martinez | Los Angeles, CA | Obstetrics & Gynecology | $124.27 |
| Carla Spades | Los Angeles, CA | Obstetrics & Gynecology | $124.27 |
| Allison Axtell | Sylmar, CA | Obstetrics & Gynecology | $124.27 |
Prescribed Dysis V3 Digital Coploscope?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.